TickerFactsScreenerDevelopers

Celldex Therapeutics, Inc. (CLDX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$36.85M2010: -$6.46M2011: -$43.40M2012: -$58.08M2013: -$81.44M2014: -$122.43M2015: -$129.54M2016: -$132.92M2017: -$121.53M2018: -$156.44M2019: -$55.03M2020: -$63.35M2021: -$71.24M2022: -$115.23M2023: -$154.54M2024: -$195.08M2025: -$287.37M-$287.37M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$287.37M-47.3%
2024-$195.08M-26.2%
2023-$154.54M-34.1%
2022-$115.23M-61.7%
2021-$71.24M-12.5%
2020-$63.35M-15.1%
2019-$55.03M+64.8%
2018-$156.44M-28.7%
2017-$121.53M+8.6%
2016-$132.92M-2.6%
2015-$129.54M-5.8%
2014-$122.43M-50.3%
2013-$81.44M-40.2%
2012-$58.08M-33.8%
2011-$43.40M-572.3%
2010-$6.46M+82.5%
2009-$36.85M—